Piperidine, pyrrolidine and 2-oxo-1,3-oxazinane derivatives as inhibitors of bacterial efflux-pumps for the treatment of microbial infections
WO2017042099A1
Efflux-pump inhibitors and therapeutic uses thereof
WO2016198691A1
Efflux-pump inhibitors and therapeutic uses thereof
WO2015173341A1
Dosage principle for anti-cancer furazanylbenzimidazoles
CN104837855A
Selected macrolides with PDE4-inhibiting activity
SI2882723T1
Process for the manufacture of isavuconazole or ravuconazole
AU2013289384A1
Combination therapy for the treatment of cancer and immunosuppression
AU2012233003A1
Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
CA2838036A1
Tricyclic antibiotics
CA2828381A1
Use of phospho-akt as a biomarker of drug response
AU2012219611A1
Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazoles
CN103328978A
Use of stathmin as a biomarker of drug response to furazanobenzimidazoles
CA2822491A1
Use of bubr1 as a biomarker of drug response to furazanobenzimidazoles
HUE031162T2
Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles
CN102666548A
Tricyclic antibiotics
WO2011018510A1
New macrolides and their use
AU2010277688A1
Furazanobenzimidazoles as prodrugs to treat neoplastic or autoimmune diseases
AU2010206161A1
Novel bicyclic antibiotics
WO2010072672A1
New crystal polymorphs of ceftobiprole
KR20110005714A
Crystalline (6r,7r)-7-{2-(5-amino-[1,2,4]thiadiazol-3-yl)-2-[(z)-trityloxyimino]-acetylamino}-3-[(r)-1'-tert-butoxycarbonyl-2-oxo-[1,3']bipyrrolidinyl-(3e)-ylidenemethyl]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester; its manufacture and use
